Nanotechnology

NCI established the Nanotechnology Characterization Laboratory (NCL) to support the extramural research community to accelerate the progress of nanomedicine by providing preclinical characterization and safety testing of nanoparticles. It is a collaborative effort between NCI, the US Food and Drug Administration (FDA), and the National Institute of Standards and Technology (NIST). NCL performs: Characterization of strategies with proven efficacy for cancer therapy, diagnosis, or vaccines, Evaluation of novel, early-stage nanomedicine platforms with potential… [learn more]